SCHEMBL16645243

SCHEMBL16645243

CSc1nc2ccc(O)cc2c(SC)c1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.43
ESR2 Q92731 8/20 0.43
NR1I3 Q14994 2/20 0.41
CYP2C9 P11712 3/20 0.40
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
PIK3CA P42336 1/20 0.40
CYP2D6 P10635 3/20 0.39
CYP2C19 P33261 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2B6 P20813 2/20 0.39
AHR P35869 1/20 0.39
DHODH Q02127 1/20 0.38
HSP90AB1 P08238 1/20 0.38
ALOX5 P09917 1/20 0.38
HSD17B1 P14061 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16645260 0.84 ESR1 (0.42) ESR1ESR2NR1I3CYP2C9ALDH1A1
SCHEMBL789718 0.68 CYP1A1 (0.41) NR1I3CYP2C9ALDH1A1GAACYP2D6
SCHEMBL16645288 0.67 RORC (0.56) ESR1ESR2ESRRBESRRA
SCHEMBL16690488 0.66 ESR1 (0.65) ESR1ESR2CYP2C9CYP2D6CYP2C19
SCHEMBL23956547 0.66 WHR1 (0.56) ESR1ESR2CYP2C9ALDH1A1GAA
SCHEMBL1573432 0.66 NPSR1 (0.42) ALDH1A1CYP2D6CYP2C19KDM4EHPGD
SCHEMBL16645170 0.65 RORC (0.52) ESR1ESR2NR1I3ALDH1A1KDM4E
SCHEMBL16645240 0.65 PDE4B (0.47) ESR1ESR2ALDH1A1KDM4EHPGD
SCHEMBL10673740 0.65 KDM4E (0.53) ESR1ESR2CYP2C9ALDH1A1GAA
SCHEMBL4558537 0.64 KMT2A (0.55) ESR1ESR2ALDH1A1GAAPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160279122-A1 PHENYL LINKED QUINOLINYL MODULATORS OF RORgammat JANSSEN PHARMACEUTICA NV (BE) 2016-09-29 US disclosed
US-9403816-B2 Phenyl linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV (BE) 2016-08-02 US disclosed
US-20150105404-A1 PHENYL LINKED QUINOLINYL MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (BE) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160279122-A1 PHENYL LINKED QUINOLINYL MODULATORS OF RORgammat RORC, RORB, RORA ESR1 1296/4885ESR2 427/4885NR1I3 13/4885
US-20150105404-A1 PHENYL LINKED QUINOLINYL MODULATORS OF RORyt RORC, RORA, RORB ESR1 1297/4885ESR2 653/4885NR1I3 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.